The quality of laboratory testing today: an assessment of sigma metrics for analytic quality using performance data from proficiency testing surveys and the CLIA criteria for acceptable performance.

To assess the analytic quality of laboratory testing in the United States, we obtained proficiency testing survey results from several national programs that comply with Clinical Laboratory Improvement Amendments (CLIA) regulations. We studied regulated tests (cholesterol, glucose, calcium, fibrinogen, and prothrombin time) and nonregulated tests (international normalized ratio [INR], glycohemoglobin, and prostate-specific antigen [PSA]). Quality was assessed on the sigma scale with a benchmark for minimum process performance of 3 sigma and a goal for world-class quality of 6 sigma. Based on the CLIA criteria for acceptable performance in proficiency testing (allowable total errors [TEa]), the national quality of cholesterol testing (TEa = 10%) estimated sigma values as 2.9 to 3.0; glucose (TEa = 10%), 2.9 to 3.3; calcium (TEa = 1.0 mg/dL), 2.8 to 3.0; prothrombin time (TEa = 15%), 1.8; INR (TEa = 20%), 2.4 to 3.5; fibrinogen (TEa = 20%), 1.8 to 3.2; glycohemoglobin (TEa = 10%), 1.9 to 2.6; and PSA (TEa = 10%), 1.2 to 1.8. The analytic quality of laboratory tests requires improvement in measurement performance and more intensive quality control monitoring than the CLIA minimum of 2 levels per day.

[1]  D Stöckl,et al.  Proposed guidelines for the internal quality control of analytical results in the medical laboratory. , 1996, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

[2]  Medicare, Medicaid, and CLIA programs; laboratory requirements relating to quality systems and certain personnel qualifications. Final rule. , 2003, Federal register.

[3]  P. Wood,et al.  National Cholesterol Education Program recommendations for measurement of high-density lipoprotein cholesterol: executive summary. The National Cholesterol Education Program Working Group on Lipoprotein Measurement. , 1995, Clinical chemistry.

[4]  G. Burtless,et al.  Five Years After , 1949 .

[5]  Mario Plebani,et al.  Errors in laboratory medicine. , 2002, Clinical chemistry.

[6]  A. Killeen,et al.  Creatinine measurement: state of the art in accuracy and interlaboratory harmonization. , 2005, Archives of pathology & laboratory medicine.

[7]  James O. Westgard,et al.  Clinical quality vs analytical performance: what are the right targets and target values? , 2004 .

[8]  P. Pronovost,et al.  Five years after to err is human , 2005 .

[9]  Richard Schroeder,et al.  Six Sigma: The Breakthrough Management Strategy Revolutionizing the World's Top Corporations , 1999 .

[10]  E. Stein,et al.  National Cholesterol Education Program recommendations for triglyceride measurement: executive summary. The National Cholesterol Education Program Working Group on Lipoprotein Measurement. , 1995, Clinical chemistry.

[11]  D Nevalainen,et al.  Evaluating laboratory performance on quality indicators with the six sigma scale. , 2000, Archives of pathology & laboratory medicine.

[12]  P. Bachorik,et al.  National Cholesterol Education Program recommendations for measurement of low-density lipoprotein cholesterol: executive summary. The National Cholesterol Education Program Working Group on Lipoprotein Measurement. , 1995, Clinical chemistry.

[13]  James O Westgard,et al.  Internal quality control: planning and implementation strategies , 2003, Annals of clinical biochemistry.

[14]  J O Westgard,et al.  Precision requirements for cost-effective operation of analytical processes. , 1990, Clinical chemistry.

[15]  W Greg Miller,et al.  Specimen materials, target values and commutability for external quality assessment (proficiency testing) schemes. , 2003, Clinica chimica acta; international journal of clinical chemistry.

[16]  J O Westgard,et al.  Laboratory process specifications for assuring quality in the U.S. National Cholesterol Education Program. , 1991, Clinical chemistry.

[17]  M Plebani,et al.  Mistakes in a stat laboratory: types and frequency. , 1997, Clinical chemistry.

[19]  Mogens Lytken Larsen,et al.  A Comparison of Analytical Goals for Haemoglobin A1c Assays Derived Using Different Strategies , 1991, Annals of clinical biochemistry.

[20]  L. Kohn,et al.  To Err Is Human : Building a Safer Health System , 2007 .

[21]  James O. Westgard,et al.  Equivalent Quality Testing Versus Equivalent QC Procedures , 2005 .

[22]  J O Westgard,et al.  Cholesterol operational process specifications for assuring the quality required by CLIA proficiency testing. , 1991, Clinical chemistry.